Who makes [11C]BMT-136088?

[11C]BMT-136088 is developed by Bristol-Myers Squibb.

Last reviewed 2026-04-19 · How we verify

[11C]BMT-136088

Bristol-Myers Squibb · Phase 1 active Small molecule

At a glance

Generic name	[11C]BMT-136088
Sponsor	Bristol-Myers Squibb
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[11C]BMT-136088 CI brief — competitive landscape report
[11C]BMT-136088 updates RSS · CI watch RSS
Bristol-Myers Squibb portfolio CI